Docking Studies, Cytotoxicity Evaluation and Interactions of Binuclear Copper(II) Complexes with S-Isoalkyl Derivatives of Thiosalicylic Acid with Some Relevant Biomolecules.

CT26 cells DNA interaction antitumor activity binuclear copper(II) complexes colon cancer cytotoxicity docking studies inflammation

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Aug 2023
Historique:
received: 01 07 2023
revised: 29 07 2023
accepted: 01 08 2023
medline: 12 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

The numerous side effects of platinum based chemotherapy has led to the design of new therapeutics with platinum replaced by another transition metal. Here, we investigated the interactions of previously reported copper(II) complexes containing S-isoalkyl derivatives, the salicylic acid with guanosine-5'-monophosphate and calf thymus DNA (CT-DNA) and their antitumor effects, in a colon carcinoma model. All three copper(II) complexes exhibited an affinity for binding to CT-DNA, but there was no indication of intercalation or the displacement of ethidium bromide. Molecular docking studies revealed a significant affinity of the complexes for binding to the minor groove of B-form DNA, which coincided with DNA elongation, and a higher affinity for binding to Z-form DNA, supporting the hypothesis that the complex binding to CT-DNA induces a local transition from B-form to Z-form DNA. These complexes show a moderate, but selective cytotoxic effect toward colon cancer cells in vitro. Binuclear complex of copper(II) with S-isoamyl derivative of thiosalicylic acid showed the highest cytotoxic effect, arrested tumor cells in the G2/M phase of the cell cycle, and significantly reduced the expression of inflammatory molecules pro-IL-1β, TNF-α, ICAM-1, and VCAM-1 in the tissue of primary heterotopic murine colon cancer, which was accompanied by a significantly reduced tumor growth and metastases in the lung and liver.

Identifiants

pubmed: 37569878
pii: ijms241512504
doi: 10.3390/ijms241512504
pmc: PMC10420076
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Bioorg Chem. 2021 Jan;106:104479
pubmed: 33272712
Biol Direct. 2021 Dec 9;16(1):25
pubmed: 34886882
Hum Mutat. 2003 Mar;21(3):271-6
pubmed: 12619112
Cancer Res. 2007 Feb 1;67(3):1038-45
pubmed: 17283136
J Inorg Biochem. 2009 May;103(5):833-44
pubmed: 19324417
Acc Chem Res. 2015 Sep 15;48(9):2622-31
pubmed: 26247558
Med Res Rev. 2010 Jul;30(4):708-49
pubmed: 19626597
J Inorg Biochem. 2017 Oct;175:167-178
pubmed: 28755574
Proc Natl Acad Sci U S A. 1981 Apr;78(4):2179-83
pubmed: 6941276
J Mammary Gland Biol Neoplasia. 2005 Oct;10(4):299-310
pubmed: 16924372
Biochemistry. 1983 Nov 8;22(23):5409-17
pubmed: 6652071
J Cell Physiol. 2020 Mar;235(3):2911-2924
pubmed: 31535374
Oncogene. 2004 Apr 12;23(16):2825-37
pubmed: 15077146
Cancer Res. 2001 May 15;61(10):4253-7
pubmed: 11358852
Chem Rev. 1999 Sep 8;99(9):2451-66
pubmed: 11749486
Chem Rev. 2014 Jan 8;114(1):815-62
pubmed: 24102434
In Vivo. 1989 Jul-Aug;3(4):267-70
pubmed: 2519864
Oncol Rep. 2014 Jan;31(1):255-61
pubmed: 24253852
Biochem Biophys Res Commun. 2019 Jan 22;508(4):1215-1220
pubmed: 30558789
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Anticancer Agents Med Chem. 2022;22(5):999-1011
pubmed: 34238173
J Cell Biochem. 1998 Jun 1;69(3):326-35
pubmed: 9581871
Curr Pharm Des. 2010 Jun;16(16):1813-25
pubmed: 20337575
N Engl J Med. 2007 May 24;356(21):2131-42
pubmed: 17522398
Gastroenterology. 2008 Jan;134(1):29-38
pubmed: 18022173
Sci Rep. 2019 Nov 15;9(1):16937
pubmed: 31729451
Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9031-5
pubmed: 8415649
Ann Intern Med. 2015 Sep 1;163(5):347-55
pubmed: 26302241
Inorg Chem. 2009 Feb 16;48(4):1309-22
pubmed: 19140687
J Inorg Biochem. 2020 Jul;208:111078
pubmed: 32442761
J Photochem Photobiol B. 2013 Aug 5;125:56-62
pubmed: 23748130
Inorg Chem. 2011 Dec 19;50(24):12852-66
pubmed: 22074239
Inorg Chem. 2013 Mar 18;52(6):2880-90
pubmed: 23452070
Inorg Chem. 2004 Dec 27;43(26):8510-9
pubmed: 15606200
Eur J Cancer. 2005 Aug;41(12):1802-10
pubmed: 16051479
J Clin Invest. 2008 Feb;118(2):560-70
pubmed: 18219394
Inorg Chem. 2012 Jul 16;51(14):7699-710
pubmed: 22742945
Eur J Med Chem. 2015 Jan 27;90:876-88
pubmed: 25535953
J Gastrointestin Liver Dis. 2014 Dec;23(4):413-8
pubmed: 25532000
Cancer Cell. 2002 Apr;1(3):289-98
pubmed: 12086865
Sci Rep. 2017 Jul 17;7(1):5626
pubmed: 28717171
Dalton Trans. 2021 Mar 21;50(11):3990-4007
pubmed: 33650599
N Engl J Med. 2003 Mar 6;348(10):883-90
pubmed: 12621132
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Gut. 2014 Nov;63(11):1755-9
pubmed: 24488498
Thromb Res. 2009 May;124(1):80-3
pubmed: 19136145
Int J Biochem Cell Biol. 2013 May;45(5):960-3
pubmed: 23391749
Carcinogenesis. 2004 Oct;25(10):1925-34
pubmed: 15217903
J Am Chem Soc. 2001 Jun 27;123(25):5878-91
pubmed: 11414820
Dalton Trans. 2016 Mar 28;45(12):5052-63
pubmed: 26674970
Dalton Trans. 2009 Oct 7;(37):7588-98
pubmed: 19759927
Methods Enzymol. 2000;321:353-69
pubmed: 10909066
Biochem Biophys Res Commun. 1997 Jul 30;236(3):604-10
pubmed: 9245697
Inorg Chem. 2009 Mar 16;48(6):2652-63
pubmed: 19267508
Int J Mol Sci. 2021 Jul 16;22(14):
pubmed: 34299247
Anticancer Agents Med Chem. 2007 Jan;7(1):75-93
pubmed: 17266506
Chem Soc Rev. 2008 Jan;37(1):68-83
pubmed: 18197334
Front Oncol. 2022 Nov 23;12:1052672
pubmed: 36505809
Eur J Med Chem. 2014 Sep 12;84:17-29
pubmed: 25014746
Future Med Chem. 2020 May;12(10):897-914
pubmed: 32267176
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Bioorg Chem. 2022 Dec;129:106176
pubmed: 36209564
Biophys Rev. 2019 Jun;11(3):383-387
pubmed: 31119604
J Clin Invest. 1999 Aug;104(3):263-9
pubmed: 10430607
Sci Rep. 2019 Mar 27;9(1):5237
pubmed: 30918270
Eur J Med Chem. 2018 Feb 10;145:350-359
pubmed: 29335201
Clin Cancer Res. 2006 Dec 1;12(23):7165-73
pubmed: 17145842
QJM. 2001 Aug;94(8):445-8
pubmed: 11493722
Nano Lett. 2017 Feb 8;17(2):928-937
pubmed: 28139118
N Engl J Med. 2003 Mar 6;348(10):891-9
pubmed: 12621133
J Inorg Biochem. 2010 Feb;104(2):171-9
pubmed: 19939459
Nucleic Acids Res. 1985 Sep 11;13(17):6017-34
pubmed: 4047939
Cancer Microenviron. 2015 Dec;8(3):187-200
pubmed: 26686225
BMC Cancer. 2017 Sep 7;17(1):637
pubmed: 28882113
Dalton Trans. 2013 May 21;42(19):7210-23
pubmed: 23529726
Mucosal Immunol. 2014 Sep;7(5):1106-15
pubmed: 24424523
J Med Chem. 2012 Mar 8;55(5):1957-68
pubmed: 22313179
Nature. 2022 Jun;606(7914):594-602
pubmed: 35614224
Molecules. 2023 Jan 14;28(2):
pubmed: 36677900
Annu Rev Biochem. 2004;73:39-85
pubmed: 15189136
Eur J Pharm Sci. 2022 Feb 1;169:106092
pubmed: 34879254
Int J Cancer. 1998 Feb 20;79(1):76-81
pubmed: 9495363
PLoS One. 2013 Sep 09;8(9):e71982
pubmed: 24039729

Auteurs

Jelena D Dimitrijević (JD)

Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Serbia, Svetozara Markovića 69, 34000 Kragujevac, Serbia.

Natalija Solovjova (N)

Academy of Applied Studies Belgrade, The College of Health Science, Cara Dušana 254, 11080 Belgrade, Serbia.

Andriana M Bukonjić (AM)

Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.

Dušan Lj Tomović (DL)

Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.

Mirjana Milinkovic (M)

Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Serbia, Svetozara Markovića 69, 34000 Kragujevac, Serbia.

Angelina Caković (A)

Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovic 12, 34000 Kragujevac, Serbia.

Jovana Bogojeski (J)

Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovic 12, 34000 Kragujevac, Serbia.

Zoran R Ratković (ZR)

Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovic 12, 34000 Kragujevac, Serbia.

Goran V Janjić (GV)

National Institute of the Republic of Serbia, Department of Chemistry, Technology and Metallurgy, University of Belgrade-Institute of Chemistry, Njegoševa 12, 11000 Belgrade, Serbia.

Aleksandra A Rakić (AA)

Faculty of Physical Chemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.

Nebojsa N Arsenijevic (NN)

Faculty of Medical Sciences, Department of Microbiology and Immunology, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.

Marija Z Milovanovic (MZ)

Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Serbia, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Faculty of Medical Sciences, Department of Microbiology and Immunology, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.

Jelena Z Milovanovic (JZ)

Center for Harm Reduction of Biological and Chemical Hazards, Faculty of Medical Sciences, University of Kragujevac, Serbia, Svetozara Markovića 69, 34000 Kragujevac, Serbia.
Faculty of Medical Sciences, Department of Histology and Embryology, University of Kragujevac, Svetozara Markovića 69, 34000 Kragujevac, Serbia.

Gordana P Radić (GP)

Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.

Verica V Jevtić (VV)

Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovic 12, 34000 Kragujevac, Serbia.

Classifications MeSH